Marc-Philipp Pfeil is currently working as a Senior Director, Corporate Development & Strategy at BioNTech SE, previously having experience as a Life Sciences Consultant at L.E.K. Consulting. Prior to that, Pfeil was a Postdoctoral Research Fellow at Harvard Medical School, with a focus on infectious disease research. Pfeil holds a PhD in Biochemistry, Biophysics and Molecular Biology from the University of Oxford and a Bachelor of Science in Biochemistry from Imperial College London.
December, 2022 - present
April, 2021